Healthcare -
Biotechnology - NASDAQ - US
$ 20.905
-4.13 %
$ 1.03 B
Market Cap
-11.13
P/E
ELVN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ELVN - Enliven Therapeutics, Inc.
133 M
LAST VALUE
771.90%
2 YEAR CAGR
25.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR